| Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration F Herisson, V Frodermann, G Courties, D Rohde, Y Sun, K Vandoorne, ... Nature neuroscience 21 (9), 1209-1217, 2018 | 457 | 2018 |
| Sleep modulates haematopoiesis and protects against atherosclerosis CS McAlpine, MG Kiss, S Rattik, S He, A Vassalli, C Valet, A Anzai, ... Nature 566 (7744), 383-387, 2019 | 395 | 2019 |
| Atherosclerosis: the interplay between lipids and immune cells F Schaftenaar, V Frodermann, J Kuiper, E Lutgens Current opinion in lipidology 27 (3), 209-215, 2016 | 298 | 2016 |
| Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells V Frodermann, D Rohde, G Courties, N Severe, MJ Schloss, H Amatullah, ... Nature medicine 25 (11), 1761-1771, 2019 | 242 | 2019 |
| Tissue-specific macrophage responses to remote injury impact the outcome of subsequent local immune challenge FF Hoyer, K Naxerova, MJ Schloss, M Hulsmans, AV Nair, P Dutta, ... Immunity 51 (5), 899-914. e7, 2019 | 156 | 2019 |
| Differential effects of regulatory T cells on the initiation and regression of atherosclerosis AC Foks, V Frodermann, M Ter Borg, KLL Habets, I Bot, Y Zhao, ... Atherosclerosis 218 (1), 53-60, 2011 | 137 | 2011 |
| A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus V Frodermann, TA Chau, S Sayedyahossein, JM Toth, DE Heinrichs, ... Journal of infectious Diseases 204 (2), 253-262, 2011 | 124 | 2011 |
| Macrophages and cardiovascular health V Frodermann, M Nahrendorf Physiological reviews 98 (4), 2523-2569, 2018 | 115 | 2018 |
| Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche M Krohn-Grimberghe, MJ Mitchell, MJ Schloss, OF Khan, G Courties, ... Nature biomedical engineering 4 (11), 1076-1089, 2020 | 108 | 2020 |
| Neutrophil–macrophage cross-talk in acute myocardial infarction V Frodermann, M Nahrendorf European Heart Journal 38 (3), 198-200, 2017 | 76 | 2017 |
| Glucocorticoids regulate bone marrow B lymphopoiesis after stroke G Courties, V Frodermann, L Honold, Y Zheng, F Herisson, MJ Schloss, ... Circulation research 124 (9), 1372-1385, 2019 | 70 | 2019 |
| Mesenchymal stem cells reduce murine atherosclerosis development V Frodermann, J van Duijn, M van Pel, PJ van Santbrink, I Bot, J Kuiper, ... Scientific reports 5 (1), 15559, 2015 | 70 | 2015 |
| Imaging the vascular bone marrow niche during inflammatory stress K Vandoorne, D Rohde, HY Kim, G Courties, G Wojtkiewicz, L Honold, ... Circulation research 123 (4), 415-427, 2018 | 66 | 2018 |
| B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis MJ Schloss, M Hulsmans, D Rohde, IH Lee, N Severe, BH Foy, FE Pulous, ... Nature immunology 23 (4), 605-618, 2022 | 62 | 2022 |
| Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular disease D Rohde, K Vandoorne, IH Lee, J Grune, S Zhang, CS McAlpine, ... Nature cardiovascular research 1 (1), 28-44, 2022 | 56 | 2022 |
| T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis AC Foks, IA Ran, L Wasserman, V Frodermann, MND Ter Borg, ... Arteriosclerosis, thrombosis, and vascular biology 33 (11), 2558-2565, 2013 | 52 | 2013 |
| CD11b + Gr-1 + myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice AC Foks, GHM Van Puijvelde, J Wolbert, MJ Kröner, V Frodermann, ... Cardiovascular research 111 (3), 252-261, 2016 | 38 | 2016 |
| Interference of the CD30–CD30L pathway reduces atherosclerosis development AC Foks, I Bot, V Frodermann, SCA de Jager, M Ter Borg, ... Arteriosclerosis, thrombosis, and vascular biology 32 (12), 2862-2868, 2012 | 33 | 2012 |
| Oxidized Low-Density Lipoprotein–Induced Apoptotic Dendritic Cells as a Novel Therapy for Atherosclerosis V Frodermann, GHM van Puijvelde, L Wierts, HM Lagraauw, AC Foks, ... The Journal of Immunology 194 (5), 2208-2218, 2015 | 31 | 2015 |
| Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development AC Foks, IA Ran, V Frodermann, I Bot, PJ van Santbrink, J Kuiper, ... PLoS One 8 (12), e83134, 2013 | 23 | 2013 |
